These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31018720)

  • 1. Investigational antiviral therapies for the treatment of influenza.
    Yang J; Huang Y; Liu S
    Expert Opin Investig Drugs; 2019 May; 28(5):481-488. PubMed ID: 31018720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Affinity purification of influenza virus ribonucleoprotein complexes from the chromatin of infected cells.
    Chase GP; Schwemmle M
    J Vis Exp; 2012 Jun; (64):e4028. PubMed ID: 22688655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza virus resistance to antiviral therapy.
    van der Vries E; Schutten M; Fraaij P; Boucher C; Osterhaus A
    Adv Pharmacol; 2013; 67():217-46. PubMed ID: 23886002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigational hemagglutinin-targeted influenza virus inhibitors.
    Zeng LY; Yang J; Liu S
    Expert Opin Investig Drugs; 2017 Jan; 26(1):63-73. PubMed ID: 27918208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel antiviral drug discovery strategies to tackle drug-resistant mutants of influenza virus strains.
    Shin WJ; Seong BL
    Expert Opin Drug Discov; 2019 Feb; 14(2):153-168. PubMed ID: 30585088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baloxavir marboxil: the new influenza drug on the market.
    O'Hanlon R; Shaw ML
    Curr Opin Virol; 2019 Apr; 35():14-18. PubMed ID: 30852344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for Novel Small-Molecule Inhibitors Targeting the Assembly of Influenza Virus Polymerase Complex by a Bimolecular Luminescence Complementation-Based Reporter System.
    Li C; Wang Z; Cao Y; Wang L; Ji J; Chen Z; Deng T; Jiang T; Cheng G; Qin FX
    J Virol; 2017 Mar; 91(5):. PubMed ID: 28031371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza chemotherapy: a review of the present state of art and of new drugs in development.
    Lüscher-Mattli M
    Arch Virol; 2000; 145(11):2233-48. PubMed ID: 11205114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of influenza A nucleoprotein body domain residues essential for viral RNA expression expose antiviral target.
    Davis AM; Ramirez J; Newcomb LL
    Virol J; 2017 Feb; 14(1):22. PubMed ID: 28173821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Learning from structure-based drug design and new antivirals targeting the ribonucleoprotein complex for the treatment of influenza.
    Monod A; Swale C; Tarus B; Tissot A; Delmas B; Ruigrok RW; Crépin T; Slama-Schwok A
    Expert Opin Drug Discov; 2015 Apr; 10(4):345-71. PubMed ID: 25792362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanded table: Antiviral drugs for treatment and prophylaxis of seasonal influenza 2018-2019.
    Med Lett Drugs Ther; 2019 Jan; 61(1563):e11-e12. PubMed ID: 30681664
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiviral drugs for treatment and prophylaxis of seasonal influenza.
    Med Lett Drugs Ther; 2019 Jan; 61(1563):1-4. PubMed ID: 30681660
    [No Abstract]   [Full Text] [Related]  

  • 13. Type II transmembrane serine proteases as potential target for anti-influenza drug discovery.
    Shin WJ; Seong BL
    Expert Opin Drug Discov; 2017 Nov; 12(11):1139-1152. PubMed ID: 28870104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the molecular mechanism of action between drug and RNA polymerase based on partially-resolved spatial structures.
    Sheng Y; Zhang C; Qiu X; Zheng W; Ruan J; Shao Y
    Curr Comput Aided Drug Des; 2013 Dec; 9(4):547-55. PubMed ID: 24138396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adaptive mutation PB2 D701N promotes nuclear import of influenza vRNPs in mammalian cells.
    Sediri H; Schwalm F; Gabriel G; Klenk HD
    Eur J Cell Biol; 2015; 94(7-9):368-74. PubMed ID: 26074198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging antiviral therapies and drugs for the treatment of influenza.
    Wang J; Sun Y; Liu S
    Expert Opin Emerg Drugs; 2022 Dec; 27(4):389-403. PubMed ID: 36396398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From neuraminidase inhibitors to conjugates: a step towards better anti-influenza drugs?
    Cheng CK; Tsai CH; Shie JJ; Fang JM
    Future Med Chem; 2014 May; 6(7):757-74. PubMed ID: 24941871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of herpesvirus and influenza virus replication by blocking polymerase subunit interactions.
    Palù G; Loregian A
    Antiviral Res; 2013 Sep; 99(3):318-27. PubMed ID: 23748148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Baloxavir marboxil: a potent cap-dependent endonuclease inhibitor of influenza viruses].
    Reina J; Reina N
    Rev Esp Quimioter; 2019 Feb; 32(1):1-5. PubMed ID: 30676002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral susceptibility of influenza viruses isolated from patients pre- and post-administration of favipiravir.
    Takashita E; Ejima M; Ogawa R; Fujisaki S; Neumann G; Furuta Y; Kawaoka Y; Tashiro M; Odagiri T
    Antiviral Res; 2016 Aug; 132():170-7. PubMed ID: 27321665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.